Accelerated Resolution Therapy for Early Maladaptive Grief

Description

The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs). Additionally, to better understand predictors of response to ART, and cognitive processes that occur among grieving individuals following ART.

Conditions

Grief

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs). Additionally, to better understand predictors of response to ART, and cognitive processes that occur among grieving individuals following ART.

Accelerated Resolution Therapy for Early Maladaptive Grief: A Clinical Trial

Accelerated Resolution Therapy for Early Maladaptive Grief

Condition
Grief
Intervention / Treatment

-

Contacts and Locations

Jacksonville

Mayo Clinic Florida, Jacksonville, Florida, United States, 32224

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Primary caregiver of immediate family member who has a life expectancy of less than 12 months
  • * Score of 30 or higher on the PG-12-R, indicating clinically significant pre-loss grief
  • * Denial of suicidal ideation or intent, with no evidence of psychotic behavior.
  • * Since becoming a family caregiver (FCG), they have engaged in another trauma based psychotherapeutic regimen (EMDR, prolonged exposure therapy, trauma focused cognitive behavioral therapy) that could influence response to accelerated resolution therapy (ART).
  • * Self-reported or clinically assessed major psychiatric disorder (e.g., bipolar disorder, schizophrenia).
  • * Score of \> 2 on the adapted CAGE questionnaire indicating alcohol /drug dependence.
  • * Cognitive impairment (SPMSQ \> 4 errors).

Ages Eligible for Study

60 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Mayo Clinic,

Cindy Tofthagen, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2028-03-14